- Home
- PTGX vs FULT Comparison
PTGX vs FULT Comparison
Compare PTGX & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- FULT
- Stock Information
- Founded
- PTGX 2006
- FULT 1882
- Country
- PTGX United States
- FULT United States
- Employees
- PTGX N/A
- FULT N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- FULT Major Banks
- Sector
- PTGX Health Care
- FULT Finance
- Exchange
- PTGX Nasdaq
- FULT Nasdaq
- Market Cap
- PTGX 2.8B
- FULT 3.3B
- IPO Year
- PTGX 2016
- FULT N/A
- Fundamental
- Price
- PTGX $41.65
- FULT $21.24
- Analyst Decision
- PTGX Strong Buy
- FULT Hold
- Analyst Count
- PTGX 7
- FULT 5
- Target Price
- PTGX $53.57
- FULT $18.40
- AVG Volume (30 Days)
- PTGX 700.6K
- FULT 1.5M
- Earning Date
- PTGX 11-07-2024
- FULT 01-14-2025
- Dividend Yield
- PTGX N/A
- FULT 3.18%
- EPS Growth
- PTGX N/A
- FULT N/A
- EPS
- PTGX 2.68
- FULT 1.58
- Revenue
- PTGX $323,795,000.00
- FULT $1,083,452,000.00
- Revenue This Year
- PTGX $396.93
- FULT N/A
- Revenue Next Year
- PTGX N/A
- FULT $2.77
- P/E Ratio
- PTGX $15.15
- FULT $13.18
- Revenue Growth
- PTGX 125.73
- FULT 4.83
- 52 Week Low
- PTGX $16.80
- FULT $13.84
- 52 Week High
- PTGX $48.89
- FULT $21.65
- Technical
- Relative Strength Index (RSI)
- PTGX 41.01
- FULT 65.80
- Support Level
- PTGX $33.31
- FULT $20.41
- Resistance Level
- PTGX $48.86
- FULT $21.35
- Average True Range (ATR)
- PTGX 2.82
- FULT 0.61
- MACD
- PTGX -0.62
- FULT 0.06
- Stochastic Oscillator
- PTGX 53.63
- FULT 89.98
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About FULT Fulton Financial Corporation
Fulton Financial is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey, and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.